Management approaches for best outcome vary by location. Glaucoma is exceeded only by cataracts as a cause of blindness. In 2002, the World Health Organization estimated that 12.3 million people worldwide had been blinded by glaucoma.

In the event of an oculolinctus craze, we are ready (thanks to The Daily Mail and others). This summer, Western media leapt upon a post on Japanese curation site Naver Matome which detailed a sudden increase in the practice of oculolinctus.

Corneal cross-linking (CXL) is having a transformative impact on the treatment of keratoconus and post-laser ectasia.

A stark picture of an overstretched, fragile service, often at odds with hospital management, is painted in a recent RCO report. What can be done?

Free glaucoma simulation app reinforces the importance of taking medication. A recently-launched free app for iPhones and iPads will help newly diagnosed glaucoma patients better understand how the condition will affect their vision as it worsens, reinforcing the importance of taking prescribed eye drops and attending eye clinic.

Why the pharmaceutical industry is making acquisitions in ophthalmology – and why it won’t stop. The world’s pharmaceutical companies have fallen heavily for the charms of ophthalmology in recent times, with a string of acquisitions and product launches, including:

The level of hypertensive retinopathy is an independent long-term risk factor. A recent study has demonstrated that retinal photographs can reveal the future stroke risk of hypertensive patients –

The global obesity pandemic is causing a chronic cardiovascular and diabetic disease crisis. Advances in retinal microvascular imaging offer hope in tackling these problems… but are ophthalmologists ready for a prominent role in the fight against systemic disease?

Is the future of eyedrops preservative-free? Itching. Irritation. Dry eye. In extreme cases, keratosis and scarring. Adverse events occur in one in 10 patients who are on long-term therapy with eyedrops for conditions like glaucoma or uveitis. For many, these side-effects are caused by preservatives.

Stereotactic radiation therapy is a new treatment aimed at wet age-related macular degeneration. The results of a randomized, sham-controlled trial are encouraging.